Related Experiment Video
Updated: Jun 3, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
Published on: March 1, 2024
CREB is a novel nuclear target of PTEN phosphatase
Tingting Gu1, Zhong Zhang, Jianli Wang
1Institute of Systems Biomedicine, Peking University Health Science Center, Beijing, China.
Abstract:
PTEN phosphatase is a potent tumor suppressor that regulates multiple cellular functions. In the cytoplasm, PTEN dephosphorylates its primary lipid substrate, phosphatidylinositol 3,4,5-trisphosphate, to antagonize the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. It has also become increasingly evident that PTEN functions in the nucleus and may play an important part in transcription regulation, but its nuclear targets remain elusive. In this report, we demonstrate the transcription factor cyclic AMP response element-binding protein (CREB) is a protein target of PTEN phosphatase and that PTEN deficiency leads to CREB phosphorylation independent of the PI3K/AKT pathway. Using confocal immunofluorescence and reciprocal immunoprecipitation, we further show that PTEN colocalizes with CREB and physically interacts with CREB. Moreover, we use both in vitro and in vivo experiments to show PTEN can dephosphorylate CREB in a phosphatase-dependent manner, suggesting that CREB is a substrate of PTEN nuclear phosphatase. Loss of Pten results in an elevated RNA level of multiple CREB transcriptional targets and increased cell proliferation, which can be reversed by a nonphosphorylatable CREB mutant or knockdown of CREB. These data reveal a mechanism for PTEN modulation of CREB-mediated gene transcription and cell growth. Our study thus characterizes PTEN as a nuclear phophatase of a transcription factor and identifies CREB as a novel protein target of PTEN phosphatase, which contributes to better understanding of PTEN function in the nucleus.
Insights
The tumor suppressor PTEN dephosphorylates the transcription factor CREB in the nucleus, regulating gene transcription and cell growth independently of the PI3K/AKT pathway. This identifies CREB as a novel PTEN target, clarifying PTEN
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- PTEN is a crucial tumor suppressor regulating cellular functions via PI3K/AKT pathway antagonism.
- PTEN's nuclear functions and targets in transcription regulation are largely unknown.
- Identifying nuclear PTEN targets is key to understanding its role in cell growth and cancer.
Purpose of the Study:
- To identify novel nuclear protein targets of PTEN phosphatase.
- To elucidate the role of PTEN in regulating transcription factor activity.
- To understand PTEN's contribution to cell proliferation control.
Main Methods:
- Confocal immunofluorescence and reciprocal immunoprecipitation to assess PTEN-CREB interaction.
- In vitro and in vivo phosphatase assays to determine PTEN's effect on CREB phosphorylation.
- Analysis of CREB target gene expression and cell proliferation upon Pten modulation.
Main Results:
- PTEN directly dephosphorylates the transcription factor CREB in a phosphatase-dependent manner.
- PTEN physically interacts with and colocalizes with CREB in the nucleus.
- Loss of Pten elevates CREB target gene expression and cell proliferation, reversible by CREB manipulation.
Conclusions:
- PTEN acts as a nuclear phosphatase targeting the transcription factor CREB.
- PTEN's dephosphorylation of CREB modulates gene transcription and cell proliferation.
- This study reveals a novel mechanism of PTEN tumor suppression via nuclear action on CREB.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of Nuclear Protein Sorting
Canonical Wnt Signaling Pathway
Receptor Tyrosine Kinases

